Table 1.
Lymphoblastoid cell line |
gDNA (%112A/%112G) | cDNA (%112A/%112G) | ||
1st Run | 2nd Run | 1st Run | 2nd Run | |
1 | 56.4/43.6 | 54.7/45.3 | 54.7/45.3 | 59.8/50.2 |
2 | 54.7/45.3 | 52.7/47.3 | 40.6/59.4 | 59.2/40.8 |
3 | 100.0/0.0 | 100.0/0.0 | 100.0/0.0 | 100.0/0.0 |
4 | 48.7/51.3 | 46.8/53.2 | 39.5/60.5 | 45.1/54.9 |
5 | 56.6/43.4 | 57.2/42.8 | 61.6/38.4 | 54.2/45.8 |
6 | 100.0/0.0 | 100.0/0.0 | 100.0/0.0 | 100.0/0.0 |
7 | 57.5/42.5 | 53.0/47.0 | 60.8/39.2 | 56.2/43.8 |
8 | 56.5/43.5 | 55.3/44.7 | 58.3/41.7 | 59.4/40.6 |
9 | 0.0/100.0 | 0.0/100.0 | 0.0/100.0 | 0.0/100.0 |
10 | 0.0/100.0 | 0.0/100.0 | 0.0/100.0 | 0.0/100.0 |
11 | 0.0/100.0 | 0.0/100.0 | 0.0/100.0 | 5.9/94.1 |
12 | 0.0/100.0 | 0.0/100.0 | 0.0/100.0 | 0.0/100.0 |
13 | 53.1/46.9 | 55.2/44.8 | 60.0/40.0 | 55.1/44.9 |
14 | 56.3/43.7 | 54.9/45.1 | 45.9/54.1 | 62.5/37.5 |
15 | 56.7/43.3 | 55.7/44.3 | 59.3/40.7 | 69.2/30.8 |
16 | 56.0/44.0 | 54.9/45.1 | 59.3/40.7 | 53.1/46.9 |
17 | 57.6/42.4 | 51.7/48.3 | 63.6/36.4 | 56.5/43.5 |
18 | 54.7/45.3 | 50.1/49.9 | 60.0/40.0 | 54.6/45.4 |
19 | 52.9/47.1 | 56.5/43.5 | 51.2/48.8 | 51.5/48.5 |
20 | 54.4/45.6 | 52.8/47.2 | 52.7/47.3 | 51.4/48.6 |
21 | 100.0/0.0 | 100.0/0.0 | 96.6/3.4 | 100.0/0.0 |
22 | 100.0/0.0 | 100.0/0.0 | 100.0/0.0 | 100.0/0.0 |
23 | 56.2/43.8 | 56.0/44.0 | 62.6/37.4 | 52.2/47.8 |
24 | 55.0/45.0 | 53.2/46.8 | 0.0/100.0 | 0.0/100.0 |
25 | 100.0/0.0 | 100.0/0.0 | 100.0/0.0 | 96.8/3.2 |
26 | 54.1/45.9 | 54.7/45.3 | 0.0/100.0 | 0.0/100.0 |
27 | 100.0/0.0 | 100.0/0.0 | 100.0/0.0 | 97.1/2.9 |
28 | 49.6/50.4 | 52.0/48.0 | 59.7/40.3 | 59.3/40.7 |
29 | 52.3/47.7 | 50.5/49.5 | 52.1/47.9 | 48.4/51.6 |
Lymphoblastoid cell lines with an absolute depletion of 38Ser-coding alleles (112A) at the cDNA level are highlighted with bold.